Gonadotropin releasing hormone agonist triggering for in vitro maturation cycles

References

• Albuz, F. K., Sasseville, M., Lane, M., Armstrong, D. T., Thompson, J. G., & Gilchrist, R. B. (2010). Simulated physiological oocyte maturation (SPOM): A novel in vitro maturation system that substantially improves embryo yield and pregnancy outcomes. Human Reproduction (Oxford, England), 25(12), 2999–3011. https://doi.org/10.1093/humrep/deq246
   PubMed Web of Science ®Google Scholar
• Al-Inany, H. G., Youssef, M. A., Ayeleke, R. O., Brown, J., Lam, W. S., & Broekmans, F. J. (2016). Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. The Cochrane Database of Systematic Reviews, 4, CD001750. https://doi.org/10.1002/14651858.CD001750.pub4
   PubMedGoogle Scholar
• Badawy, A., Elnashar, A., El-Ashry, M., & Shahat, M. (2009). Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: Prospective randomized study. Fertility and Sterility, 91(3), 694–697. https://doi.org/10.1016/j.fertnstert.2007.12.044
   PubMed Web of Science ®Google Scholar
• Beck-Fruchter, R., Weiss, A., Lavee, M., Geslevich, Y., & Shalev, E. (2012). Empty follicle syndrome: successful treatment in a recurrent case and review of the literature. Human Reproduction (Oxford, England), 27(5), 1357–1367. https://doi.org/10.1093/humrep/des037
   PubMed Web of Science ®Google Scholar
• Blumenfeld, Z., & Evron, A. (2016). Endocrine prevention of chemotherapy-induced ovarian failure. Current Opinion in Obstetrics & Gynecology, 28(4), 223–229. https://doi.org/10.1097/GCO.0000000000000278
   PubMed Web of Science ®Google Scholar
• Creux, H., Monnier, P., Son, W. Y., Tulandi, T., & Buckett, W. (2017). Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic treatment. Fertility and Sterility, 107(1), 198–204. https://doi.org/10.1016/j.fertnstert.2016.09.041
   PubMed Web of Science ®Google Scholar
• Dahan, M. H., Tan, S. L., Chung, J., & Son, W. Y. (2016). Clinical definition paper on in vitro maturation of human oocytes. Human Reproduction (Oxford, England), 31(7), 1383–1386. https://doi.org/10.1093/humrep/dew109
   PubMed Web of Science ®Google Scholar
• Dahan, M. H., Zhang, L., Chen, H. Y., & Tan, S. L. (2016). Early short stimulation modified natural cycle IVF With GnRH agonist trigger and in vitro maturation in a woman with polycystic ovary syndrome: A case report. Journal of Obstetrics and Gynaecology Canada: JOGC = Journal d'obstetrique et gynecologie du Canada: JOGC, 38(5), 465–469. https://doi.org/10.1016/j.jogc.2016.02.002
   PubMed Web of Science ®Google Scholar
• De Vos, A., Van de Velde, H., Joris, H., & Van Steirteghem, A. (1999). In-vitro matured metaphase-I oocytes have a lower fertilization rate but similar embryo quality as mature metaphase-II oocytes after intracytoplasmic sperm injection. Human Reproduction (Oxford, England), 14(7), 1859–1863. https://doi.org/10.1093/humrep/14.7.1859
   PubMed Web of Science ®Google Scholar
• Devroey, P., & Adriaensen, P. (2011). OHSS free clinic. Facts, Views & Vision in Obgyn, 3(1), 43–45. https://www.fvvo.be/archive/volume-3/number-1/viewpoint/ohss-free-clinic/
   PubMedGoogle Scholar
• Engmann, L., Benadiva, C., & Humaidan, P. (2016). GnRH agonist trigger for the induction of oocyte maturation in GnRH antagonist IVF cycles: A SWOT analysis. Reproductive Biomedicine Online, 32(3), 274–285. https://doi.org/10.1016/j.rbmo.2015.12.007
   PubMed Web of Science ®Google Scholar
• Gardner, D. K., Surrey, E., Minjarez, D., Leitz, A., Stevens, J., & Schoolcraft, W. B. (2004). Single blastocyst transfer: A prospective randomized trial. Fertility and Sterility, 81(3), 551–555. https://doi.org/10.1016/j.fertnstert.2003.07.023
   PubMed Web of Science ®Google Scholar
• Gilchrist, R. B., Luciano, A. M., Richani, D., Zeng, H. T., Wang, X., Vos, M. D., Sugimura, S., Smitz, J., Richard, F. J., & Thompson, J. G. (2016). Oocyte maturation and quality: Role of cyclic nucleotides. Reproduction (Cambridge, England), 152(5), R143–R157. https://doi.org/10.1530/REP-15-0606
   PubMed Web of Science ®Google Scholar
• Griesinger, G., Diedrich, K., Devroey, P., & Kolibianakis, E. M. (2006). GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: A systematic review and meta-analysis. Human Reproduction Update, 12(2), 159–168. https://doi.org/10.1093/humupd/dmi045
   PubMed Web of Science ®Google Scholar
• Grynberg, M., Poulain, M., Le Parco, S., Sifer, C., Fanchin, R., & Frydman, N. (2016). Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients. Human Reproduction (Oxford, England), 31(3), 623–629. https://doi.org/10.1093/humrep/dev325
   PubMed Web of Science ®Google Scholar
• Hatırnaz, S., Hatırnaz, E., Dahan, M. H., Tan, S. L., Ozer, A., Kanat-Pektas, M., & Ata, B. (2016). Is elective single-embryo transfer a viable treatment policy in in vitro maturation cycles? Fertility and Sterility, 106(7), 1691–1695. https://doi.org/10.1016/j.fertnstert.2016.08.026
   PubMed Web of Science ®Google Scholar
• Hershko Klement, A., Ovadia, M., Wiser, A., Berkovitz, A., Shavit, T., Nemerovsky, L., Ghetler, Y., Cohen, I., & Shulman, A. (2017). What we learned from extended culture of ‘rejected’ day-3 cleavage stage embryos: A prospective cohort study. Journal of Ovarian Research, 10(1), 35. https://doi.org/10.1186/s13048-017-0332-5
   PubMedGoogle Scholar
• Hershko Klement, A., & Shulman, A. (2017). hCG triggering in ART: An evolutionary concept. International Journal of Molecular Sciences, 18(5), 1075. https://doi.org/10.3390/ijms18051075
   Web of Science ®Google Scholar
• Khalili, M. A., Shahedi, A., Ashourzadeh, S., Nottola, S. A., Macchiarelli, G., & Palmerini, M. G. (2017). Vitrification of human immature oocytes before and after in vitro maturation: A review. Journal of Assisted Reproduction and Genetics, 34(11), 1413–1426. https://doi.org/10.1007/s10815-017-1005-4
   PubMed Web of Science ®Google Scholar
• Kol, S., & Humaidan, P. (2010). LH (as HCG) and FSH surges for final oocyte maturation: Sometimes it takes two to tango? Reproductive Biomedicine Online, 21(5), 590–592. https://doi.org/10.1016/j.rbmo.2010.06.031
   PubMed Web of Science ®Google Scholar
• Kol, S., & Humaidan, P. (2013). GnRH agonist triggering: Recent developments. Reproductive Biomedicine Online, 26(3), 226–230. https://doi.org/10.1016/j.rbmo.2012.11.002
   PubMed Web of Science ®Google Scholar
• Messinis, I. E., Messini, C. I., & Dafopoulos, K. (2014). Novel aspects of the endocrinology of the menstrual cycle. Reproductive Biomedicine Online, 28(6), 714–722. https://doi.org/10.1016/j.rbmo.2014.02.003
   PubMed Web of Science ®Google Scholar
• Orvieto, R. (2017). Triggering final follicular maturation: hCG, GnRH-agonist, or both, when and to whom? Journal of Assisted Reproduction and Genetics, 34(9), 1231–1232. https://doi.org/10.1007/s10815-017-0982-7
   PubMed Web of Science ®Google Scholar
• Pereira, N., Kelly, A. G., Stone, L. D., Witzke, J. D., Lekovich, J. P., Elias, R. T., Schattman, G. L., & Rosenwaks, Z. (2017). Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing ovarian stimulation for fertility preservation. Fertility and Sterility, 108(3), 532–538. https://doi.org/10.1016/j.fertnstert.2017.06.027
   PubMed Web of Science ®Google Scholar
• Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. (2013). In vitro maturation: A committee opinion. Fertility and Sterility, 99(3), 663–666. https://doi.org/10.1016/j.fertnstert.2012.12.031
   PubMed Web of Science ®Google Scholar
• Siristatidis, C., Sergentanis, T. N., Vogiatzi, P., Kanavidis, P., Chrelias, C., Papantoniou, N., & Psaltopoulou, T. (2015). In vitro maturation in women with vs. without polycystic ovarian syndrome: A systematic review and meta-analysis. PloS One, 10(8), e0134696. https://doi.org/10.1371/journal.pone.0134696
   PubMed Web of Science ®Google Scholar
• Son, W. Y., & Tan, S. L. (2010). Laboratory and embryological aspects of hCG-primed in vitro maturation cycles for patients with polycystic ovaries. Human Reproduction Update, 16(6), 675–689. https://doi.org/10.1093/humupd/dmq014
   PubMed Web of Science ®Google Scholar
• Walls, M. L., & Hart, R. J. (2018). In vitro maturation. Best Practice & Research. Clinical Obstetrics & Gynaecology, 53, 60–72. https://doi.org/10.1016/j.bpobgyn.2018.06.004
   PubMed Web of Science ®Google Scholar
• Yang, Z. Y., & Chian, R. C. (2017). Development of in vitro maturation techniques for clinical applications. Fertility and Sterility, 108(4), 577–584. https://doi.org/10.1016/j.fertnstert.2017.08.020
   PubMed Web of Science ®Google Scholar
• Yang, B., Shi, W., Yang, J., Liu, H., Zhao, H., Li, X., & Jiao, S. (2013). Concurrent treatment with gonadotropin-releasing hormone agonists for chemotherapy-induced ovarian damage in premenopausal women with breast cancer: A meta-analysis of randomized controlled trials. Breast (Edinburgh, Scotland), 22(2), 150–157. https://doi.org/10.1016/j.breast.2012.12.008
   PubMed Web of Science ®Google Scholar
• Youssef, M. A., Van der Veen, F., Al-Inany, H. G., Mochtar, M. H., Griesinger, G., Nagi Mohesen, M., Aboulfoutouh, I., & van Wely, M. (2014). Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology. The Cochrane Database of Systematic Reviews, (10), CD008046. https://doi.org/10.1002/14651858.CD008046.pub4
   PubMed Web of Science ®Google Scholar
• Zilberberg, E., Haas, J., Dar, S., Kedem, A., Machtinger, R., & Orvieto, R. (2015). Co-administration of GnRH-agonist and hCG, for final oocyte maturation (double trigger), in patients with low proportion of mature oocytes. Gynecological Endocrinology, 31(2), 145–147. https://doi.org/10.3109/09513590.2014.978850
   PubMed Web of Science ®Google Scholar